VPS9D1 and non-small cell lung carcinoma: By using the median level of VPS9D1-AS1 expression in the NSCLC tissue samples as a cutoff, all samples from the 51 NSCLC patients were classified into either VPS9D1-AS1 high-expression or VPS9D1-AS1 low-expression groups.